本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Denali Therapeutics Inc.

15.50
+0.07000.45%
成交量:217.58萬
成交額:3,348.15萬
市值:22.66億
市盈率:-5.52
高:15.69
開:15.45
低:15.06
收:15.43
52周最高:33.33
52周最低:10.57
股本:1.46億
流通股本:1.32億
量比:0.70
換手率:1.65%
股息:- -
股息率:- -
每股收益(TTM):-2.8082
每股收益(LYR):-2.5705
淨資產收益率:-39.69%
總資產收益率:-24.99%
市淨率:2.21
市盈率(LYR):-6.03

資料載入中...

2024/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities